Indeed, we demonstrated that genetic or pharmacologic inhibition of MEN1 could phenocopy the effects of PRC2 knockout in inhibiting the proliferation of EZH2 mutant and/or H3K27me3-high DLBCL and MM cells (Fig. 3). The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.